Meningioma Grading
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 21 (12) , 1455-1465
- https://doi.org/10.1097/00000478-199712000-00008
Abstract
Histologic grading of meningiomas has prognostic and sometimes therapeutic implications, but diagnostic criteria for atypical meningioma are vague, and the significance of brain invasion in the determination of malignancy remains controversial. We reviewed our experience with 581 patients whose meningiomas were resected at Mayo Clinic during the years 1978 through 1988. All patients were followed until death or a median of 9.0 years. Ten histologic parameters were assessed and compared with recurrence-free survival. On univariate analysis, six variables were associated with recurrence, although most were statistically significant only in the subset of patients having undergone gross total tumor resection. On multivariate analyses, the most significant parameters were histologic brain invasion (when assessable) and maximal mitotic rate of at least four per 10 high-power fields (HPF). Also significant were combinations of at least three of the following four parameters: hypercellularity, architectural sheeting, macronucleoli, and small cell formation. Proposed grading criteria based on these findings yielded 81% classic, 15% atypical, and 4% brain invasive meningiomas with respective 5-year recurrence rates of 12%, 41%, and 56%. There was no association between histologic grade and either extent of surgical resection or patient age. However, male sex was associated with high-grade (atypical/brain invasive) tumors. Too few frankly anaplastic meningiomas were encountered for statistical analysis. Brain invasion and an increased mitotic index (at least four per 10 HPF) are the most powerful histologic factors prognostic for recurrence in meningiomas. We propose an objective definition for atypical meningioma based on our data. Because the difference in recurrence rates for brain invasive and atypical meningiomas was not statistically significant, it could not be determined whether brain invasion alone warrants a designation of malignancy. Likewise, we were unable to determine what constitutes histologic anaplasia due to the rarity of such cases.Keywords
This publication has 51 references indexed in Scilit:
- 2028 Treatment of benign intracranial meningioma: The role of radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Cytogenetic, Molecular Genetic and Pathological Analyses in 126 MeningiomasJournal of Neuropathology and Experimental Neurology, 1995
- Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomasJournal of Neurosurgery, 1994
- Prognostic Significance of Proliferative Indices in MeningiomasJournal of Neuropathology and Experimental Neurology, 1994
- Postoperative irradiation for subtotally resected meningiomasJournal of Neurosurgery, 1994
- A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a southwest oncology group studyJournal of Neuro-Oncology, 1993
- Treatment of unresectable meningiomas with the antiprogesterone agent mifepristoneJournal of Neurosurgery, 1991
- Relationship between Flow Cytometric Features and Clinical Behavior of MeningiomasNeurosurgery, 1988
- Histopathologic Features Predicting Recurrence of Meningiomas Following Subtotal ResectionThe American Journal of Surgical Pathology, 1986
- Prediction of recurrence in meningiomas after surgical treatmentActa Neuropathologica, 1983